Literature DB >> 18509606

Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress.

Maram K Reddy1, Li Wu, Wei Kou, Anuja Ghorpade, Vinod Labhasetwar.   

Abstract

The objective of our study was to investigate the neuroprotective efficacy of superoxide dismutase (SOD), loaded in poly(D,L-lactide co-glycolide; PLGA) nanoparticles (NPs), in cultured human neurons challenged with hydrogen peroxide (H(2)O(2))-induced oxidative stress. We hypothesized that the protected and sustained intracellular delivery of SOD encapsulated in NPs would demonstrate better neuroprotection from oxidative stress than either SOD or pegylated SOD (PEG-SOD) in solution. SOD-NPs (approximately 81 +/- 4 nm in diameter, 0.9% w/w SOD loading) released the encapsulated SOD in an active form with 8.2% cumulative release during the first 24 h, followed by a slower release thereafter. The results demonstrated that PLGA-NPs are compatible with human neurons, and the neuroprotective effect of SOD-NPs is dose-dependent, with efficacy seen at >100 U SOD, and less significant effects at lower doses. Neither SOD (25-200 U) nor PEG-SOD (100 U) in solution demonstrated the neuroprotective effect under similar conditions. The neuroprotective effect of SOD-NPs was seen up to 6 h after H(2)O(2)-induced oxidative stress, but the effect diminished thereafter. Confocal microscopic studies demonstrated better intracellular neuronal uptake of the encapsulated model protein (fluorescein isothiocyanate-labeled BSA) than the protein in solution. Thus, the mechanism of efficacy of SOD-NPs appears to be due to the stability of the encapsulated enzyme and its better neuronal uptake after encapsulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509606      PMCID: PMC2670226          DOI: 10.1007/s12010-008-8232-1

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  28 in total

Review 1.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

Review 2.  Drug efflux transporters in the CNS.

Authors:  Haiying Sun; Haiqing Dai; Naveed Shaik; William F Elmquist
Journal:  Adv Drug Deliv Rev       Date:  2003-01-21       Impact factor: 15.470

Review 3.  Tight junctions of the blood-brain barrier: development, composition and regulation.

Authors:  Hartwig Wolburg; Andrea Lippoldt
Journal:  Vascul Pharmacol       Date:  2002-06       Impact factor: 5.773

4.  Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.

Authors:  Swayam Prabha; Wen-Zhong Zhou; Jayanth Panyam; Vinod Labhasetwar
Journal:  Int J Pharm       Date:  2002-09-05       Impact factor: 5.875

5.  Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons.

Authors:  S M de la Monte; T R Neely; J Cannon; J R Wands
Journal:  Cell Mol Life Sci       Date:  2000-09       Impact factor: 9.261

Review 6.  Modulation of oxidant and antioxidant enzyme expression and function in vascular cells.

Authors:  Sven Wassmann; Kerstin Wassmann; Georg Nickenig
Journal:  Hypertension       Date:  2004-08-30       Impact factor: 10.190

7.  Modulation of ATP levels alters the mode of hydrogen peroxide-induced cell death in primary cortical cultures: effects of putative neuroprotective agents.

Authors:  Funan Huang; Mohan C Vemuri; J S Schneider
Journal:  Brain Res       Date:  2004-01-30       Impact factor: 3.252

8.  The 2007 Feinberg lecture: a new road map for neuroprotection.

Authors:  Geoffrey A Donnan
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

Review 9.  Role of superoxide dismutases in oxidative damage and neurodegenerative disorders.

Authors:  Carolina M Maier; Pak H Chan
Journal:  Neuroscientist       Date:  2002-08       Impact factor: 7.519

Review 10.  Oxidants, antioxidants and the ischemic brain.

Authors:  David S Warner; Huaxin Sheng; Ines Batinić-Haberle
Journal:  J Exp Biol       Date:  2004-08       Impact factor: 3.312

View more
  40 in total

Review 1.  Functionalized nanosystems for targeted mitochondrial delivery.

Authors:  Shelley A Durazo; Uday B Kompella
Journal:  Mitochondrion       Date:  2011-11-23       Impact factor: 4.160

Review 2.  Novel roles for α-crystallins in retinal function and disease.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Prog Retin Eye Res       Date:  2012-06-18       Impact factor: 21.198

3.  Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury.

Authors:  Yue Gao; Sivakumar Vijayaraghavalu; Melinda Stees; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2019-03-28       Impact factor: 9.776

4.  Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles.

Authors:  Jacob W Myerson; Bruce Braender; Olivia Mcpherson; Patrick M Glassman; Raisa Y Kiseleva; Vladimir V Shuvaev; Oscar Marcos-Contreras; Martha E Grady; Hyun-Su Lee; Colin F Greineder; Radu V Stan; Russell J Composto; David M Eckmann; Vladimir R Muzykantov
Journal:  Adv Mater       Date:  2018-06-28       Impact factor: 30.849

5.  Mesoscale nanoparticles selectively target the renal proximal tubule epithelium.

Authors:  Ryan M Williams; Janki Shah; Brandon D Ng; Denise R Minton; Lorraine J Gudas; Christopher Y Park; Daniel A Heller
Journal:  Nano Lett       Date:  2015-03-26       Impact factor: 11.189

6.  Advances in stroke therapy.

Authors:  Hayder Jaffer; Viola B Morris; Desiree Stewart; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2011-12-01       Impact factor: 4.617

Review 7.  Enzymes as Immunotherapeutics.

Authors:  Shaheen A Farhadi; Evelyn Bracho-Sanchez; Sabrina L Freeman; Benjamin G Keselowsky; Gregory A Hudalla
Journal:  Bioconjug Chem       Date:  2018-01-31       Impact factor: 4.774

8.  Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury.

Authors:  Xiang Yun; Victor D Maximov; Jin Yu; Hong Zhu; Alexey A Vertegel; Mark S Kindy
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

9.  Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain.

Authors:  Marianne Petro; Hayder Jaffer; Jun Yang; Shushi Kabu; Viola B Morris; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

Review 10.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.